Medpace Holdings, Inc.: what the price is pricing in

The price implies cash-flow growth of 9.6% a year; our model expects 20.0%. That gap is wide enough for a long position this quarter. Switch lens below to see the same question asked of earnings, growth, sales and book value.

What growth in cash flow is the price paying for?

The price implies cash-flow growth of 9.6% a year; our model expects 20.0%.

Market more pessimistic than our model: long this quarter

What the price implies What our model expects

Quarters with a position1919 long, 0 short, since September 30, 2017

Beat the S&P 50014 of 1973.7% of quarters held

Strategy against the index+350.4%cumulative; worst fall -18.9%

$10,000 became$148,906S&P 500 bought and held: $34,842

Over time

The growth in owner earnings (free cash flow after stock-based pay) that would justify the share price in our discounted-cash-flow model, against the growth the model itself assumes from the company's record.

Growth our model assumes Growth the price implies Long quarter Short quarter. Lower panel: the share price at each quarter end, adjusted for later share splits and spin-offs (the table below gives the price as traded).

$10,000 trading the gap vs the S&P 500

StrategyS&P 500, buy and hold Hypothetical, before costs. The strategy holds the S&P 500 and only changes on a signal: it switches into MEDP in long quarters and adds a short of MEDP in short quarters. The gap between the lines is what the signal added or lost.

Skill or luck?

In plain English: Across 19 quarters with a position, this lens beat the S&P 500 in 14, by +9.3% a quarter on average. That stands out clearly from chance. One company is a small sample: the results across all companies are the better guide.

Positions	Quarters	Beat the S&P 500	Average vs S&P 500, a quarter	Typical (median), a quarter	A year	Confidence (t)	Evidence
Longs	19	73.7%	+9.3%	+7.6%	+37.3%	2.55	Strong evidence
Shorts	0	—	—	—	—	—	—
All positions	19	73.7%	+9.3%	+7.6%	+37.3%	2.55	Strong evidence

Each position is measured against the S&P 500 over the same quarter: a long earns the stock's return minus the index's, a short the index's minus the stock's. "A year" compounds the per-quarter results. Evidence: strong at a t-statistic of 2 or more, some from 1.5; "worse" when the result is that far below zero; one company's history is a small sample, so read these alongside the results across all companies.

Every quarter (37)

From	Price paid	Growth the price implies	Growth our model assumes	Position	MEDP	S&P 500
September 30, 2026 (open)	$624.18	9.6%	20.0%	Long	+3.8%	−0.8%
June 30, 2026	$529.59	7.5%	20.0%	Long	+17.9%	+2.4%
March 31, 2026	$480.19	6.9%	20.0%	Long	+10.3%	+15.1%
December 31, 2025	$561.65	11.0%	16.8%	No position	−14.5%	−4.4%
September 30, 2025	$514.16	11.8%	15.1%	No position	+9.2%	+2.7%
June 30, 2025	$313.86	4.0%	15.5%	Long	+63.8%	+8.1%
March 31, 2025	$304.69	4.0%	17.3%	Long	+3.0%	+10.8%
December 31, 2024	$332.23	7.2%	20.0%	Long	−8.3%	−4.3%
September 30, 2024	$333.80	8.1%	20.0%	Long	−0.5%	+2.5%
June 30, 2024	$411.85	12.6%	20.0%	No position	−18.9%	+5.8%
March 31, 2024	$404.15	13.9%	20.0%	No position	+1.9%	+4.4%
December 31, 2023	$306.53	10.0%	20.0%	Long	+31.9%	+10.4%
September 30, 2023	$242.13	7.0%	20.0%	Long	+26.6%	+11.6%
June 30, 2023	$240.17	8.1%	20.0%	Long	+0.8%	−3.2%
March 31, 2023	$188.05	4.7%	20.0%	Long	+27.7%	+8.7%
December 31, 2022	$212.41	8.9%	20.0%	Long	−11.5%	+7.5%
September 30, 2022	$157.17	6.3%	20.0%	Long	+35.1%	+7.6%
June 30, 2022	$149.67	7.3%	20.0%	Long	+5.0%	−4.9%
March 31, 2022	$163.59	8.9%	20.0%	Long	−8.5%	−16.1%
December 31, 2021	$217.64	15.2%	20.0%	No position	−24.8%	−4.6%
September 30, 2021	$189.28	13.5%	19.6%	No position	+15.0%	+11.1%
June 30, 2021	$176.63	13.5%	11.0%	No position	+7.2%	+0.6%
March 31, 2021	$164.05	13.1%	12.0%	No position	+7.7%	+8.4%
December 31, 2020	$139.20	12.4%	12.1%	No position	+17.9%	+6.3%
September 30, 2020	$111.75	8.2%	19.7%	Long	+24.6%	+12.1%
June 30, 2020	$93.02	4.5%	20.0%	Long	+20.1%	+9.0%
March 31, 2020	$73.38	1.6%	20.0%	Long	+26.8%	+20.2%
December 31, 2019	$84.06	5.3%	20.0%	Long	−12.7%	−19.4%
September 30, 2019	$84.04	5.9%	13.0%	No position	+0.0%	+9.0%
June 30, 2019	$65.42	3.6%	13.0%	No position	+28.5%	+1.8%
March 31, 2019	$58.97	3.4%	13.0%	No position	+10.9%	+4.2%
December 31, 2018	$52.93	3.5%	13.0%	No position	+11.4%	+13.5%
September 30, 2018	$59.91	8.2%	20.0%	Long	−11.7%	−13.5%
June 30, 2018	$43.00	5.6%	14.9%	No position	+39.3%	+7.7%
March 31, 2018	$34.91	6.0%	3.5%	No position	+23.2%	+3.5%
December 31, 2017	$36.26	7.5%	5.5%	No position	−3.7%	−1.0%
September 30, 2017	$31.90	6.4%	8.9%	No position	+13.7%	+6.8%

Price paid: the closing price that day as traded, before any later share split.

What growth in earnings is the price paying for?

The price implies earnings growth of 15.4% a year; our model expects 20.0%.

Gap too narrow for a position this quarter

What the price implies What our model expects

Quarters with a position63 long, 3 short, since September 30, 2017

Beat the S&P 5003 of 650.0% of quarters held

Strategy against the index+7.7%cumulative; worst fall -23.1%

$10,000 became$37,262S&P 500 bought and held: $34,842

Over time

The earnings growth the price-to-earnings ratio requires, against the growth our model assumes. Net income is already after interest, so it is valued at the return shareholders require, plus spare cash (none for banks and insurers, whose cash is funded by deposits and policies), with no debt subtracted.

Growth our model assumes Growth the P/E implies Long quarter Short quarter. Lower panel: the share price at each quarter end, adjusted for later share splits and spin-offs (the table below gives the price as traded).

$10,000 trading the gap vs the S&P 500

Skill or luck?

In plain English: With only 6 quarters of positions, Medpace Holdings, Inc.'s own record is too short to tell skill from luck. The results across all companies on the priced-in page are the better guide.

Positions	Quarters	Beat the S&P 500	Average vs S&P 500, a quarter	Typical (median), a quarter	A year	Confidence (t)	Evidence
Longs	3	66.7%	+13.0%	+19.0%	+56.7%	1.22	Too few quarters
Shorts	3	33.3%	−7.9%	−6.9%	−29.6%	-1.23	Too few quarters
All positions	6	50.0%	+2.5%	−2.1%	+5.0%	0.34	Too few quarters

Every quarter (37)

From	Price paid	Growth the P/E implies	Growth our model assumes	Position	MEDP	S&P 500
September 30, 2026 (open)	$624.18	15.4%	20.0%	No position	+3.8%	−0.8%
June 30, 2026	$529.59	13.6%	20.0%	No position	+17.9%	+2.4%
March 31, 2026	$480.19	12.3%	20.0%	No position	+10.3%	+15.1%
December 31, 2025	$561.65	16.1%	16.8%	No position	−14.5%	−4.4%
September 30, 2025	$514.16	15.6%	15.1%	No position	+9.2%	+2.7%
June 30, 2025	$313.86	7.3%	15.5%	No position	+63.8%	+8.1%
March 31, 2025	$304.69	7.2%	17.3%	Long	+3.0%	+10.8%
December 31, 2024	$332.23	10.8%	20.0%	No position	−8.3%	−4.3%
September 30, 2024	$333.80	12.5%	20.0%	No position	−0.5%	+2.5%
June 30, 2024	$411.85	18.1%	20.0%	No position	−18.9%	+5.8%
March 31, 2024	$404.15	19.7%	20.0%	No position	+1.9%	+4.4%
December 31, 2023	$306.53	15.4%	20.0%	No position	+31.9%	+10.4%
September 30, 2023	$242.13	11.4%	20.0%	No position	+26.6%	+11.6%
June 30, 2023	$240.17	12.4%	20.0%	No position	+0.8%	−3.2%
March 31, 2023	$188.05	9.0%	20.0%	Long	+27.7%	+8.7%
December 31, 2022	$212.41	12.5%	20.0%	No position	−11.5%	+7.5%
September 30, 2022	$157.17	9.3%	20.0%	Long	+35.1%	+7.6%
June 30, 2022	$149.67	10.4%	20.0%	No position	+5.0%	−4.9%
March 31, 2022	$163.59	13.3%	20.0%	No position	−8.5%	−16.1%
December 31, 2021	$217.64	18.8%	20.0%	No position	−24.8%	−4.6%
September 30, 2021	$189.28	17.1%	19.6%	No position	+15.0%	+11.1%
June 30, 2021	$176.63	17.5%	11.0%	No position	+7.2%	+0.6%
March 31, 2021	$164.05	18.0%	12.0%	No position	+7.7%	+8.4%
December 31, 2020	$139.20	17.9%	12.1%	No position	+17.9%	+6.3%
September 30, 2020	$111.75	16.5%	19.7%	No position	+24.6%	+12.1%
June 30, 2020	$93.02	13.0%	20.0%	No position	+20.1%	+9.0%
March 31, 2020	$73.38	10.1%	20.0%	No position	+26.8%	+20.2%
December 31, 2019	$84.06	14.3%	20.0%	No position	−12.7%	−19.4%
September 30, 2019	$84.04	15.3%	13.0%	No position	+0.0%	+9.0%
June 30, 2019	$65.42	13.0%	13.0%	No position	+28.5%	+1.8%
March 31, 2019	$58.97	12.3%	13.0%	No position	+10.9%	+4.2%
December 31, 2018	$52.93	13.3%	13.0%	No position	+11.4%	+13.5%
September 30, 2018	$59.91	18.4%	20.0%	No position	−11.7%	−13.5%
June 30, 2018	$43.00	14.8%	14.9%	No position	+39.3%	+7.7%
March 31, 2018	$34.91	14.2%	3.5%	Short	+23.2%	+3.5%
December 31, 2017	$36.26	22.0%	5.5%	Short	−3.7%	−1.0%
September 30, 2017	$31.90	23.7%	8.9%	Short	+13.7%	+6.8%

Price paid: the closing price that day as traded, before any later share split.

Is the price-to-earnings ratio cheap or dear for the growth delivered?

Medpace Holdings, Inc. trades on 36.3 times earnings while its earnings per share grew 26.8% a year: a PEG of 1.36.

Gap too narrow for a position this quarter

PEG: under 0.75 cheap for the growth, over 3 expensive

Quarters with a position1111 long, 0 short, since March 31, 2020

Beat the S&P 5009 of 1181.8% of quarters held

Strategy against the index+306.5%cumulative; worst fall -7.8%

$10,000 became$119,875S&P 500 bought and held: $32,355

Over time

The P/E divided by the earnings-per-share growth delivered over three years. Under 0.75 the market pays little for the growth (long); over 3 it pays a lot (short).

EPS growth, 3 years (%) Price-to-earnings ratio (x) Long quarter Short quarter. Lower panel: the share price at each quarter end, adjusted for later share splits and spin-offs (the table below gives the price as traded).

$10,000 trading the gap vs the S&P 500

Skill or luck?

In plain English: Across 11 quarters with a position, this lens beat the S&P 500 in 9, by +14.6% a quarter on average. That stands out clearly from chance. One company is a small sample: the results across all companies are the better guide.

Positions	Quarters	Beat the S&P 500	Average vs S&P 500, a quarter	Typical (median), a quarter	A year	Confidence (t)	Evidence
Longs	11	81.8%	+14.6%	+11.5%	+66.5%	2.93	Strong evidence
Shorts	0	—	—	—	—	—	—
All positions	11	81.8%	+14.6%	+11.5%	+66.5%	2.93	Strong evidence

Every quarter (27)

From	Price paid	Price-to-earnings ratio (x)	EPS growth, 3 years (%)	Position	MEDP	S&P 500
September 30, 2026 (open)	$624.18	36.3x	26.8%	No position	+3.8%	−0.8%
June 30, 2026	$529.59	33.3x	26.4%	No position	+17.9%	+2.4%
March 31, 2026	$480.19	30.8x	28.0%	No position	+10.3%	+15.1%
December 31, 2025	$561.65	37.4x	30.3%	No position	−14.5%	−4.4%
September 30, 2025	$514.16	35.8x	32.7%	No position	+9.2%	+2.7%
June 30, 2025	$313.86	23.5x	34.7%	Long	+63.8%	+8.1%
March 31, 2025	$304.69	24.0x	37.8%	Long	+3.0%	+10.8%
December 31, 2024	$332.23	29.1x	33.1%	No position	−8.3%	−4.3%
September 30, 2024	$333.80	31.5x	31.8%	No position	−0.5%	+2.5%
June 30, 2024	$411.85	42.2x	32.3%	No position	−18.9%	+5.8%
March 31, 2024	$404.15	45.5x	32.1%	No position	+1.9%	+4.4%
December 31, 2023	$306.53	35.6x	37.4%	No position	+31.9%	+10.4%
September 30, 2023	$242.13	28.5x	43.5%	Long	+26.6%	+11.6%
June 30, 2023	$240.17	30.1x	39.2%	No position	+0.8%	−3.2%
March 31, 2023	$188.05	24.8x	39.7%	Long	+27.7%	+8.7%
December 31, 2022	$212.41	30.2x	37.5%	No position	−11.5%	+7.5%
September 30, 2022	$157.17	25.3x	34.3%	Long	+35.1%	+7.6%
June 30, 2022	$149.67	27.2x	36.6%	Long	+5.0%	−4.9%
March 31, 2022	$163.59	34.0x	34.5%	No position	−8.5%	−16.1%
December 31, 2021	$217.64	44.7x	42.7%	No position	−24.8%	−4.6%
September 30, 2021	$189.28	40.7x	49.5%	No position	+15.0%	+11.1%
June 30, 2021	$176.63	41.7x	53.5%	No position	+7.2%	+0.6%
March 31, 2021	$164.05	42.5x	57.8%	Long	+7.7%	+8.4%
December 31, 2020	$139.20	42.3x	69.3%	Long	+17.9%	+6.3%
September 30, 2020	$111.75	39.0x	70.8%	Long	+24.6%	+12.1%
June 30, 2020	$93.02	32.1x	82.8%	Long	+20.1%	+9.0%
March 31, 2020	$73.38	27.6x	93.4%	Long	+26.8%	+20.2%

Price paid: the closing price that day as traded, before any later share split.

What profit margin is the price paying for?

The price implies an owner-earnings margin of 13.7%; the company has kept 24.3%.

Market more pessimistic than our model: long this quarter

What the price implies What the company delivered

Quarters with a position2828 long, 0 short, since September 30, 2017

Beat the S&P 50018 of 2864.3% of quarters held

Strategy against the index+390.1%cumulative; worst fall -36.9%

$10,000 became$161,530S&P 500 bought and held: $34,842

Over time

The owner-earnings margin (free cash flow after stock pay, as a share of revenue) the price requires at our model's growth, against the margin the company has delivered over three years.

Margin delivered Margin the price implies Long quarter Short quarter. Lower panel: the share price at each quarter end, adjusted for later share splits and spin-offs (the table below gives the price as traded).

$10,000 trading the gap vs the S&P 500

Skill or luck?

In plain English: Across 28 quarters with a position, this lens beat the S&P 500 in 18, by +7.0% a quarter on average. That stands out clearly from chance. One company is a small sample: the results across all companies are the better guide.

Positions	Quarters	Beat the S&P 500	Average vs S&P 500, a quarter	Typical (median), a quarter	A year	Confidence (t)	Evidence
Longs	28	64.3%	+7.0%	+6.7%	+25.5%	2.25	Strong evidence
Shorts	0	—	—	—	—	—	—
All positions	28	64.3%	+7.0%	+6.7%	+25.5%	2.25	Strong evidence

Every quarter (37)

From	Price paid	Margin the price implies	Margin delivered	Position	MEDP	S&P 500
September 30, 2026 (open)	$624.18	13.7%	24.3%	Long	+3.8%	−0.8%
June 30, 2026	$529.59	12.1%	24.2%	Long	+17.9%	+2.4%
March 31, 2026	$480.19	11.7%	24.1%	Long	+10.3%	+15.1%
December 31, 2025	$561.65	17.7%	24.3%	Long	−14.5%	−4.4%
September 30, 2025	$514.16	19.3%	23.2%	No position	+9.2%	+2.7%
June 30, 2025	$313.86	12.2%	23.2%	Long	+63.8%	+8.1%
March 31, 2025	$304.69	11.0%	23.0%	Long	+3.0%	+10.8%
December 31, 2024	$332.23	10.7%	21.7%	Long	−8.3%	−4.3%
September 30, 2024	$333.80	11.1%	21.4%	Long	−0.5%	+2.5%
June 30, 2024	$411.85	14.4%	21.6%	Long	−18.9%	+5.8%
March 31, 2024	$404.15	14.8%	20.6%	Long	+1.9%	+4.4%
December 31, 2023	$306.53	11.9%	20.7%	Long	+31.9%	+10.4%
September 30, 2023	$242.13	10.1%	20.8%	Long	+26.6%	+11.6%
June 30, 2023	$240.17	11.0%	21.2%	Long	+0.8%	−3.2%
March 31, 2023	$188.05	9.2%	21.6%	Long	+27.7%	+8.7%
December 31, 2022	$212.41	11.2%	20.5%	Long	−11.5%	+7.5%
September 30, 2022	$157.17	9.4%	20.1%	Long	+35.1%	+7.6%
June 30, 2022	$149.67	9.8%	19.7%	Long	+5.0%	−4.9%
March 31, 2022	$163.59	11.1%	20.4%	Long	−8.5%	−16.1%
December 31, 2021	$217.64	15.7%	20.4%	No position	−24.8%	−4.6%
September 30, 2021	$189.28	14.9%	20.8%	Long	+15.0%	+11.1%
June 30, 2021	$176.63	24.0%	20.9%	No position	+7.2%	+0.6%
March 31, 2021	$164.05	21.8%	20.5%	No position	+7.7%	+8.4%
December 31, 2020	$139.20	19.1%	18.8%	No position	+17.9%	+6.3%
September 30, 2020	$111.75	10.2%	19.2%	Long	+24.6%	+12.1%
June 30, 2020	$93.02	8.4%	19.9%	Long	+20.1%	+9.0%
March 31, 2020	$73.38	6.8%	18.9%	Long	+26.8%	+20.2%
December 31, 2019	$84.06	8.3%	18.7%	Long	−12.7%	−19.4%
September 30, 2019	$84.04	12.8%	19.1%	Long	+0.0%	+9.0%
June 30, 2019	$65.42	10.7%	18.3%	Long	+28.5%	+1.8%
March 31, 2019	$58.97	10.6%	18.1%	Long	+10.9%	+4.2%
December 31, 2018	$52.93	10.6%	18.1%	Long	+11.4%	+13.5%
September 30, 2018	$59.91	9.3%	17.8%	Long	−11.7%	−13.5%
June 30, 2018	$43.00	10.3%	17.4%	Long	+39.3%	+7.7%
March 31, 2018	$34.91	19.2%	16.6%	No position	+23.2%	+3.5%
December 31, 2017	$36.26	18.2%	16.2%	No position	−3.7%	−1.0%
September 30, 2017	$31.90	13.6%	15.7%	No position	+13.7%	+6.8%

Price paid: the closing price that day as traded, before any later share split.

What return on equity is the price paying for?

No current reading. The latest is from June 30, 2026: the figures this lens needs have not been filed recently enough (or no longer apply), so there is no position this quarter.

Quarters with a position350 long, 35 short, since September 30, 2017

Beat the S&P 50013 of 3537.1% of quarters held

Strategy against the index−93.9%cumulative; worst fall -93.9%

$10,000 became$2,503S&P 500 bought and held: $33,428

Over time

The return on equity that justifies the price-to-book ratio, (P/B)(r − g) + g with an 8.5% required return and 2.5% long-run growth, against the return the company delivered last year.

Return on equity delivered Return on equity the price implies Long quarter Short quarter. Lower panel: the share price at each quarter end, adjusted for later share splits and spin-offs (the table below gives the price as traded).

$10,000 trading the gap vs the S&P 500

Skill or luck?

In plain English: Across 35 quarters with a position, this lens beat the S&P 500 in 13, by −6.2% a quarter on average. That is reliably worse than the index: trading the gap lost money on this company. One company is a small sample: the results across all companies are the better guide.

Positions	Quarters	Beat the S&P 500	Average vs S&P 500, a quarter	Typical (median), a quarter	A year	Confidence (t)	Evidence
Longs	0	—	—	—	—	—	—
Shorts	35	37.1%	−6.2%	−6.6%	−27.4%	-2.34	Strong evidence: worse
All positions	35	37.1%	−6.2%	−6.6%	−27.4%	-2.34	Strong evidence: worse

Every quarter (35)

From	Price paid	Return on equity the price implies	Return on equity delivered	Position	MEDP	S&P 500
June 30, 2026	$529.59	156.3%	77.3%	Short	+17.9%	+2.4%
March 31, 2026	$480.19	184.2%	70.2%	Short	+10.3%	+15.1%
December 31, 2025	$561.65	333.2%	73.7%	Short	−14.5%	−4.4%
September 30, 2025	$514.16	524.1%	89.4%	Short	+9.2%	+2.7%
June 30, 2025	$313.86	101.5%	65.8%	Short	+63.8%	+8.1%
March 31, 2025	$304.69	73.1%	58.4%	Short	+3.0%	+10.8%
December 31, 2024	$332.23	75.1%	54.1%	Short	−8.3%	−4.3%
September 30, 2024	$333.80	86.7%	58.9%	Short	−0.5%	+2.5%
June 30, 2024	$411.85	120.3%	61.4%	Short	−18.9%	+5.8%
March 31, 2024	$404.15	140.8%	59.8%	Short	+1.9%	+4.4%
December 31, 2023	$306.53	126.5%	66.6%	Short	+31.9%	+10.4%
September 30, 2023	$242.13	119.8%	79.7%	Short	+26.6%	+11.6%
June 30, 2023	$240.17	135.9%	54.0%	Short	+0.8%	−3.2%
March 31, 2023	$188.05	97.0%	36.6%	Short	+27.7%	+8.7%
December 31, 2022	$212.41	120.0%	36.3%	Short	−11.5%	+7.5%
September 30, 2022	$157.17	114.7%	36.9%	Short	+35.1%	+7.6%
June 30, 2022	$149.67	56.5%	27.3%	Short	+5.0%	−4.9%
March 31, 2022	$163.59	41.4%	20.7%	Short	−8.5%	−16.1%
December 31, 2021	$217.64	57.0%	21.6%	Short	−24.8%	−4.6%
September 30, 2021	$189.28	52.8%	22.1%	Short	+15.0%	+11.1%
June 30, 2021	$176.63	49.1%	20.3%	Short	+7.2%	+0.6%
March 31, 2021	$164.05	48.6%	19.0%	Short	+7.7%	+8.4%
December 31, 2020	$139.20	42.3%	16.8%	Short	+17.9%	+6.3%
September 30, 2020	$111.75	36.4%	15.3%	Short	+24.6%	+12.1%
June 30, 2020	$93.02	32.1%	16.4%	Short	+20.1%	+9.0%
March 31, 2020	$73.38	25.4%	15.2%	Short	+26.8%	+20.2%
December 31, 2019	$84.06	30.1%	14.9%	Short	−12.7%	−19.4%
September 30, 2019	$84.04	31.1%	14.8%	Short	+0.0%	+9.0%
June 30, 2019	$65.42	26.0%	13.6%	Short	+28.5%	+1.8%
December 31, 2018	$52.93	23.4%	11.1%	Short	+11.4%	+13.5%
September 30, 2018	$59.91	26.8%	9.1%	Short	−11.7%	−13.5%
June 30, 2018	$43.00	20.4%	7.9%	Short	+39.3%	+7.7%
March 31, 2018	$34.91	18.0%	7.0%	Short	+23.2%	+3.5%
December 31, 2017	$36.26	18.1%	4.8%	Short	−3.7%	−1.0%
September 30, 2017	$31.90	15.4%	3.8%	Short	+13.7%	+6.8%

Price paid: the closing price that day as traded, before any later share split.

How the test works

At each quarter end since March 2010 we rebuild the models from Medpace Holdings, Inc.'s quarters ending at least 90 days earlier (and no more than 200 days before that), using the figures as later filed, including any restatement, and value them at that day's close, adjusted for later share splits and spin-offs so that price and share count are on the same basis. A wide enough gap is a long or a short for one quarter (growth 10 points; margin and return on equity 5 points; a PEG under 0.75 or over 3), measured on total return against the S&P 500. The rules were set before the test. No trading or borrowing costs; today's list of companies. Not investment advice. All companies and the results across them.

Compare with peers

Head to head: FTRE vs MEDP BIO vs MEDP BRKR vs MEDP MEDP vs QGEN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Medpace Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 23, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medpace Holdings, Inc.